136 Researchers at the Indian Institute of Technology (IIT) in Madras, Tel Aviv University, and Columbia University are working to develop a treatment for a rare genetic brain disease called GNB1 Encephalopathy. This neurological disorder affects fetuses and has fewer than 100 documented cases worldwide. Symptoms of GNB1 Encephalopathy include delayed physical and mental development, intellectual disabilities, and frequent epileptic seizures. Due to the high cost of genome sequencing, not many parents opt for it early on, making it difficult to diagnose and treat the disease in its early stages. You Might Be Interested In PM Anwar hosts dinner for Philippine President Marcos Jr EU Borrowing Costs Jump as Index Snub Raises Concerns Mumtalakat Funds Singapore Gulf Bank to Expand Presence in Bahrain UK Trade Minister: FTA with India Possible Before Elections U.S. will help Vietnam boost its military capabilities RBI Prohibits JM Financial from Providing Financing Against Shares & Debentures Due to ‘Serious Deficiencies